neuraminidase inhibitor


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.
Related to neuraminidase inhibitor: Oseltamivir, amantadine, Tamiflu, Zanamivir

neuraminidase inhibitor

Infectious disease Any antiviral that inhibits neuraminidase, an enzyme essential for replication of influenza and other viruses. See Influenza.

neuraminidase inhibitor

Any of a class of antiviral drugs that block neuraminidase, which helps the influenza virus to bud from cells it has infected so that it can spread to other ciliated epithelial cells of the respiratory tract. Agents in this class include oseltamivir and zanamivir.
See also: inhibitor
References in periodicals archive ?
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial US Oral Neuraminidase Study Group.
Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.
The magnitude of risk reduction with neuraminidase inhibitor therapy was similar in children and adults, and with oseltamivir compared with zanamivir.
MARKET SHARES OF NEURAMINIDASE INHIBITOR MANUFACTURERS, 2010
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.
FIGURE 46 EUROPEAN MARKET SHARES OF NEURAMINIDASE INHIBITOR
FIGURE 37 U S MARKET FOR NEURAMINIDASE INHIBITORS, 2009-
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
Like zanamivir, a neuraminidase inhibitor that's effective against all strains of influenza A and B.
BioCryst currently has two late-stage development programs: peramivir, a viral neuraminidase inhibitor for the treatment of influenza, and BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for the treatment of gout.
TABLE 73 EMERGING MARKET SHARES OF NEURAMINIDASE INHIBITOR MANUFACTURERS,